Browse resources
Topic: Disease/vaccine specific information
Total results with these characteristics: 871
- Economic Impact of a Rotavirus Vaccination Program in Mexico
This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …
Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y
Published: 2009
- Effect of a Conjugate Pneumococcal Vaccine on the Occurrence of Respiratory Infections and Antibiotic Use in Day-Care Center Attendees
Published in the Pediatric Infectious Disease Journal, this article examines whether the use of a pneumococcal conjugate vaccine could reduce the occurrence of respiratory infections and the ensuing antibiotic drug use in the day care. In this …
Author: Dagan R, Sikuler-Cohen M, Zamir O, et al.
Published: 2001
- Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media with Effusion
Published in the journal Pediatrics, this article assess the effect of combined pneumococcal conjugate and polysaccharide vaccinations on the recurrence of otitis media through a randomised, controlled trial.
Author: van Heerbeek N, Straetemans M, Wiertsema SP
Published: 2006
- Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …
Author: Madhi SA, Cunliffe NA, Steele D, et al.
Published: 2010
- Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico
This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 …
Author: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.
Published: 2010
- Effect of Rotavirus Vaccine on Diarrhea Mortality in Different Socioeconomic Regions of Mexico
This article, published in Pediatrics, concludes that after the 2007 introduction of rotavirus vaccine in Mexico, marked and sustained declines in diarrhea deaths were seen among children in all regions of the country, including in the least …
Author: Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, et al.
Published: 2013
- Effect of Single Dose of SA 14-14-2 Vaccine One Year After Immunisation in Nepalese Children with Japanese Encephalitis: A Case-Control Study
Published in The Lancet, investigators conducted a case-control study and efficacy of the SA 14-14-2 JE vaccine to be 98.5 percent 12 to 15 months after vaccination. ABSTRACT ONLY. (Learn how users in developing countries can gain free access …
Author: Ohrr H, Tandan JB, Sohn YM, et al.
Published: 2005
- Effect of Vaccines on Bacterial Meningitis Worldwide
This article, published in The Lancet, focuses on the three most common causes of acute bacterial meningitis: Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The authors compare patterns of meningitis attributable to …
Author: McIntyre PB, O'Brien KL, Greenwood B, van de Beek D
Published: 2012
- Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience
In 2010, Burkina Faso conducted a country-wide campaign to introduce a new Group A meningococcal conjugate vaccine, MenAfriVac™. Leading up to this effort, the following challenges were successfully managed: (1) conducting a large safety study …
Author: Djingarey MH, Barry R, Bonkoungou M, et al.
Published: 2012
- Effectiveness of Haemophilus influenzae type b Conjugate Vaccine on Prevention of Pneumonia and Meningitis in Bangladeshi Children: A Case-Control Study
Few Asian countries have introduced Haemophilus influenzae type b (Hib) conjugate vaccine because of its cost and uncertainty regarding disease burden. To estimate the effectiveness of Hib conjugate vaccine in preventing pneumonia and meningitis in …
Author: Baqui AH, El Arifeen S, Saha SK, et al.
Published: 2007
- Effectiveness of Maternal Influenza Immunization in Mothers and Infants
Young infants and pregnant women are at increased risk for serious consequences of influenza infection. Inactivated influenza vaccine is recommended for pregnant women but is not licensed for infants younger than six months of age. This study …
Author: Zaman K, Roy E, Arifeen S, et al.
Published: 2008
- Effectiveness of One Dose of SA 14-14-2 Vaccine Against Japanese Encephalitis
Correspondence, published in the New England Journal of Medicine, about a small case control study in Uttar Pradesh, India, on the efficacy of a single dose of the SA 14-14-2 JE vaccine within six months of its administration. …
Author: Kumar R, Tripathi P, Rizvi A
Published: 2009
- Efficacy of a Pneumococcal Conjugate Vaccine Against Acute Otitis Media
This study, published in the New England Journal of Medicine, enrolled 1662 infants in a randomized, double-blind efficacy trial of a heptavalent pneumococcal polysaccharide conjugate vaccine in which the carrier protein is the nontoxic …
Author: Eskola J, Kilpi T, Palmu A, et al.
Published: 2001
- Efficacy of Human Rotavirus Vaccine Against Rotavirus Gastroenteritis During the First 2 Years of Life in European Infants: Randomised, Double-Blind Controlled Study
This article, published in The Lancet, presents data that show high efficacy for GSK's Rotarix® administered with routine vaccines. Over two seasons, Rotarix® demonstrated 90 percent efficacy against severe rotavirus among European …
Author: Vesikari T, Karvonen A, Prymula R, et al.
Published: 2007
- Efficacy of Nine-valent Pneumococcal Conjugate Vaccine Against Pneumonia and Invasive Pneumococcal Disease in The Gambia: Randomized Double-Blind, Placebo-Controlled Trial
Published in The Lancet, this study aims to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children through a randomised, placebo-controlled, double-blind trial in eastern Gambia. Children age 6–51 weeks were randomly …
Author: Cutts U, Zaman SMA, Enwere G, et al.
Published: 2005
- Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Asia: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, assesses the clinical efficacy of the pentavalent, live oral rotavirus vaccine for the prevention of severe rotavirus gastroenteritis in infants in Bangladesh and Vietnam. Study results demonstrated vaccine …
Author: Zaman K, Dang DA, Victor JC, et al.
Published: 2010
- Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Sub-Saharan Africa: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, shares results of an efficacy study of the pentavalent, live oral rotavirus vaccine in Ghana, Kenya, and Mali. Results showed 39.3 percent efficacy against severe rotavirus gastroenteritis. The authors …
Author: Armah GE, Sow SO, Breiman RF, et al.
Published: 2010
- Efficacy of Pneumococcal Conjugate Vaccines and Their Effort on Carriage and Antimicrobial Resistance
Pneumococcal conjugate vaccines have shown a high degree of success in preventing pneumococcal bacteraemia in children. They also reduce the acquisition of carriage of vaccine serotypes in the nasopharynx, and reduce otitis media caused by those …
Author: Klugman K
Published: 2001
- Efficacy of RTS,S/AS01E Vaccine Against Malaria in Children 5 to 17 Months of Age
This study, published in the New England Journal of Medicine, evaluated the efficacy of the RTS,S malaria vaccine given with a more immunogenic adjuvant system (AS01E) than one used in a previous study (AS02A). The study was conducted in …
Author: Bejon P, Lusingu J, Olotu A, et al.
Published: 2008
- Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children
This study, published in the Journal of Infectious Diseases, determined that the Rotarix® vaccine produced by GlaxoSmithKline decreased the incidence severe gastroenteritis caused by rotavirus at comparable rates among well-nourished and …
Author: Perez-Schael I, Salinas B, Tomat M, et al.
Published: 2007
- Eliminating Epidemic Group A Meningococcal Meningitis in Africa Through a New Vaccine
This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in …
Author: LaForce FM, Okwo-Bele J-M
Published: 2011
- Elimination of Haemophilus influenzae type b (Hib) Disease From The Gambia After the Introduction of Routine Immunisation With a Hib Conjugate Vaccine: A Prospective Study
Routine immunization of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May 1997. This article, published in The Lancet, reports on a study that investigated the effectiveness …
Author: Adegbola RA, Secka O, Lahai G, et al.
Published: 2005
- E-medicine: Japanese Encephalitis
This article provides a comprehensive overview of the disease.
Author: Kallen A
Published: 2002
- Emergence of G12 Rotavirus Strains in Delhi, India, in 2000 to 2007
In this article, published in the Journal of Clinical Microbiology, researchers identified a broad diversity of rotavirus strains among children in India, including several unusual strains and two novel strains. The study highlights the great …
Author: Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK
Published: 2008
- Emergency or Routine Vaccination Against Meningococcal Disease in Africa?
This comment, published in The Lancet, is based on a review of the study "Emergency Vaccination Against Epidemic Meningitis in Ghana: Implications for the Control of Meningococcal Disease in West Africa." The author concludes that …
Author: Peltola H
Published: 2000

